Evaluate the change in BMI after 12 weeks on the maintenance dose and discontinue SAXENDA if the patient has not had a reduction in BMI of at least 1% from baseline, since it is unlikely that the patient will achieve and sustain clinically meaningful weight loss with continued treatment
Uncertain Results When traditional methods alone haven't been effective, program options supervised by a licensed clinician may offer a different approach
The FDAs MMF initiative will streamline regulatory approval of submissions that provide supporting data resulting from quantitative models or modeling platforms [2]
Our Certificate of Analysis (COA) provides complete molecular profiling data including sequence confirmation, retention time, and purity levels 99%
Skalny AA, Tinkov AA, Medvedeva YS, Alchinova IB, Karganov MY, Skalny AV et al (2015) Effect of short-term zinc supplementation on zinc and selenium tissue distribution and serum antioxidant enzymes